Stopped early
POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)
NCT05299606 · Ethicon, Inc. · Updated 24 Nov 2025
- What is being tested
- Transbronchial Microwave Ablation
- For
- Lung Neoplasms
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 22 years and older. About 12 people. The full rules are on the registry page.
- Where
- United States, Canada, Hong Kong (10 sites)
- When
- Starts or started 21 Oct 2022, ends 18 Oct 2024. Registered 29 March 2022.
- Results
- Posted on the registry on 24 Nov 2025.
In the researchers' words
This is a prospective, multicenter, single-arm study on transbronchial microwave ablation using the NEUWAVE FLEX Microwave Ablation System and Accessories on oligometastatic tumors in the peripheral lung, guided by the Auris MONARCH Platform for visualization and access while using cone beam CT (computed tomography) to confirm probe tip placement and final ablation zone. The primary endpoint is Technique Efficacy, assessed 30-days post-ablation via CT imaging.
Sites
- Stanford University School of MedicineStanford, California, United States
- UCONN HealthFarmington, Connecticut, United States
- Minnesota Lung CenterMinneapolis, Minnesota, United States
- FirstHealth Moore Regional HospitalPinehurst, North Carolina, United States
- Cleveland ClinicCleveland, Ohio, United States
- University of PennsylvaniaPhiladelphia, Pennsylvania, United States
- MD AndersonHouston, Texas, United States
- University of TorontoToronto, Ontario, Canada
- Centre Hospitalier de l'Universite de MontrealMontreal, Quebec, Canada
- Prince of Wales HospitalShatin, Hong Kong